ArticlePublisher preview available

Reduction of Natural Adenovirus Tropism to the Liver by both Ablation of Fiber-Coxsackievirus and Adenovirus Receptor Interaction and Use of Replaceable Short Fiber

American Society for Microbiology
Journal of Virology
Authors:
To read the full-text of this research, you can request a copy directly from the authors.

Abstract

The initial recognition and binding of adenovirus vector to the host cell surface is mediated by interaction between the adenovirus fiber knob protein and its receptor, the coxsackievirus and adenovirus receptor (CAR). This natural tropism of adenovirus vector needs to be ablated in order to achieve targeted gene transfer. To this end, we noted that adenovirus serotype 40 (Ad40) contains two distinct long and short fibers; the short fiber is unable to recognize CAR, while the long fiber binds CAR. We generated adenovirus serotype 5-based mutants with chimeric Ad40-derived fibers, which were composed of either long or short shafts together with CAR binding or nonbinding knobs. The capacity of these adenovirus mutants for in vitro and in vivo gene transfer to liver cells was examined. In the case of primary human hepatocytes displaying a high expression level of CAR and alphav integrin, both CAR binding ability and fiber shaft length played important roles in efficient transduction. Most significantly, the high transduction efficiency observed in the liver and spleen following intravenous administration of adenovirus vector was dramatically reduced by both ablation of fiber-CAR interaction and the use of replaceable short fiber. In other tissues displaying a low level of transduction, no significant differences in transduction efficiency were observed among adenovirus vector mutants. Furthermore, incorporation of a 7-lysine-residue motif at the C-terminal end of CAR-nonbinding short fiber efficiently achieved transduction of target cells via the heparan-containing receptor. Our results demonstrated that the natural tropism of adenovirus in vivo is influenced not only by fiber-CAR interaction but also by fiber shaft length. Furthermore, our strategy may be useful for retargeting adenovirus to particular tumors and tissue types with specific receptors.
JOURNAL OF VIROLOGY, Feb. 2003, p. 2512–2521 Vol. 77, No. 4
0022-538X/03/$08.000 DOI: 10.1128/JVI.77.4.2512–2521.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Reduction of Natural Adenovirus Tropism to the Liver by both
Ablation of Fiber-Coxsackievirus and Adenovirus Receptor
Interaction and Use of Replaceable Short Fiber
Takafumi Nakamura,
1,2
* Kenzo Sato,
2
and Hirofumi Hamada
1
Department of Molecular Medicine, Sapporo Medical University, S1 W17, Chuo-ku, Sapporo 060-8556,
1
and
Department of Molecular Biology, Faculty of Medicine, Tottori University, Yonago 683-8503,
2
Japan
Received 3 June 2002/Accepted 15 November 2002
The initial recognition and binding of adenovirus vector to the host cell surface is mediated by interaction
between the adenovirus fiber knob protein and its receptor, the coxsackievirus and adenovirus receptor (CAR).
This natural tropism of adenovirus vector needs to be ablated in order to achieve targeted gene transfer. To
this end, we noted that adenovirus serotype 40 (Ad40) contains two distinct long and short fibers; the short
fiber is unable to recognize CAR, while the long fiber binds CAR. We generated adenovirus serotype 5-based
mutants with chimeric Ad40-derived fibers, which were composed of either long or short shafts together with
CAR binding or nonbinding knobs. The capacity of these adenovirus mutants for in vitro and in vivo gene
transfer to liver cells was examined. In the case of primary human hepatocytes displaying a high expression
level of CAR and v integrin, both CAR binding ability and fiber shaft length played important roles in efficient
transduction. Most significantly, the high transduction efficiency observed in the liver and spleen following
intravenous administration of adenovirus vector was dramatically reduced by both ablation of fiber-CAR
interaction and the use of replaceable short fiber. In other tissues displaying a low level of transduction, no
significant differences in transduction efficiency were observed among adenovirus vector mutants. Further-
more, incorporation of a 7-lysine-residue motif at the C-terminal end of CAR-nonbinding short fiber efficiently
achieved transduction of target cells via the heparan-containing receptor. Our results demonstrated that the
natural tropism of adenovirus in vivo is influenced not only by fiber-CAR interaction but also by fiber shaft
length. Furthermore, our strategy may be useful for retargeting adenovirus to particular tumors and tissue
types with specific receptors.
Because adenovirus vectors are capable of efficiently deliv-
ering genes to a variety of cell types, they have been used in a
number of gene therapy approaches (14, 42). The initial rec-
ognition and binding of adenovirus vector to the host cell
surface is mediated by interaction between the adenovirus fiber
knob protein and the coxsackievirus and adenovirus receptor
(CAR) (3, 32, 40). However, the natural tropism of adenovirus
vector for CAR makes it impossible to restrict gene delivery to
specific cells in an efficient and safe manner. This natural
tropism may limit widespread application of adenovirus vec-
tors. Therefore, several studies have focused on ablation of
adenovirus vector tropism as a first step to redirection of ad-
enovirus vectors to specific cell and tissue targets (2, 4, 10, 18,
19, 20, 33).
A number of strategies to alter adenovirus vector tropism
have been based on modification of viral capsid protein, in
particular fiber protein (48). Chimeric vectors containing ade-
novirus serotype 3 (Ad3) (38), Ad7 (12), Ad11 (37), Ad17 (6),
or Ad35 (35, 36) fibers instead of Ad5 fiber, which recognize
receptors other than CAR, resulted in infection through CAR-
independent pathways. Furthermore, it was noted that the
natural tropism of Ad5 was removed by altering specific amino
acid residues in the fiber knob that are involved in CAR bind-
ing (2, 4, 18, 19, 20, 33).
It is well known that intravenous administration of an ade-
novirus vector results mostly in hepatocyte transduction (2, 10,
16, 20). This liver tropism prevents adenovirus vectors from
being used to target other cell types by intravenous injection.
Nevertheless, intravenously administered CAR interaction-de-
ficient adenovirus vectors primarily localized to the liver, sim-
ilar to the wild-type Ad5 vector (2, 20). Other factors apart
from CAR interaction may play a significant role in the liver
tropism displayed by adenovirus vectors. In this context, it has
recently been reported that removal of both CAR and integrin
interaction leads to effective reduction of liver tropism (10).
We noted that Ad40 contains two distinct long and short
fibers (7, 17, 22, 32, 39). The shaft domain from the Ad40 short
fiber contains 12 sheets, while its knob region was hypothe-
sized not to bind to any receptor, including CAR. On the other
hand, the shaft from the Ad40 long fiber contains 21 sheets,
while its equivalent knob region can bind CAR (32). Interest-
ingly, the N-terminal tail regions of the Ad40 short and long
fibers, which are involved in incorporating the fiber into the
penton base (7, 8), are more analogous to the corresponding
amino acid sequence regions of the Ad5 fiber than to other
adenovirus serotypes (7). As shown in Fig. 5, the adenoviral
fiber could be incorporated into the penton base in Ad5 capsid.
In addition, the CAR-binding knob from both Ad5 and Ad40
long fibers begin with a TLWT hinge sequence, whereas the
CAR-nonbinding knob from the Ad40 short fiber begins with
* Corresponding author. Present address: Molecular Medicine Pro-
gram, Mayo Foundation, Guggenheim 18, 200 First St. SW, Rochester,
MN 55905. Phone: (507) 538-0161. Fax: (507) 284-8388. E-mail:
Nakamura.Takafumi@mayo.edu.
2512
... HAdV-40 and HAdV-41 recognize CAR, but it is notable that two fibre proteins are expressed by these viruses [20,44]. One is similar to fibre encoded by group A, C and D adenoviruses whereas the other is of lower molecular weight and is considered not to bind to CAR [45,46]. The presence of a short fibre protein gives the virus resistance to acidic conditions as are found in the intestine [46]. ...
... When the short fibre protein was mutated to include a seven-lysine residue motif, normal infectivity was restored to a mutant virus which did not express the longer fibre protein. This virus gained entry to cells via heparan sulphate proteoglycans capable of acting as a receptor [45]. Whether mutations in the HAdV-41 fibre proteins could increase the virus's ability to infect liver cells in vivo is an interesting possibility. ...
Article
Full-text available
Over the past few months there have been reports of severe acute hepatitis in several hundred, otherwise healthy, immunocompetent young children. Several deaths have been recorded and a relatively large proportion of the patients have needed liver transplants. Most of the cases, so far, have been seen in the UK and in North America, but it has also been reported in many other European countries, the Middle East and Asia. Most common viruses have been ruled out as a causative agent; hepatitis A virus (HAV), hepatitis B virus (HBV) and hepatitis C virus (HCV) were not detected, nor were Epstein–Barr virus (EBV), cytomegalovirus (CMV) and human immunodeficiency virus (HIV) in many cases. A small proportion of the children had been infected with SARS-CoV-2 but these seem to be in a minority; similarly, almost none of the children had been vaccinated against COVID-19. Significantly, many of the patients were infected with adenovirus 41 (HAdV-F41). Previously, HAdV-41 had not been linked to hepatitis and is usually considered to cause gastroenteritis in both immunocompetent and immunocompromised patients. In two most recent studies, adeno-associated virus 2 (AAV2) was detected in almost all patients, together with species C and F HAdVs and human herpesvirus 6B (HHV6B). Here, I discuss the possibility that a change in tropism of HAdV-41 and changes in AAV2 may be responsible for their links to acute hepatitis.
... Several investigations have shown that mutation in the HAdV fibre gene can alter the tropism of adenoviruses [197-199, 200,201]. For example, the addition of a 7-lysine-residue motif at the C-terminal end of HAdV-F40 short fibre (which does not bind CAR) facilitated efficient transduction of target cells, which were not previously susceptible to infection, via the heparan-containing receptor [202]. In the studies of hepatitis of unknown origin, full or partial sequencing of the HAdV-F41 genome was carried out in many cases. ...
Article
Full-text available
Over 100 human adenoviruses (HAdVs) have been isolated and allocated to seven species, A-G. Species F comprises two members-HAdV-F40 and HAdV-F41. As their primary site of infection is the gastrointestinal tract they have been termed, with species A, enteric adenoviruses. HAdV-F40 and HAdV-F41 are a common cause of gastroenteritis and diarrhoea in children. Partly because of difficulties in propagating the viruses in the laboratory, due to their restrictions on growth in many cell lines, our knowledge of the properties of individual viral proteins is limited. However, the structure of HAdV-F41 has recently been determined by cryo-electron microscopy. The overall structure is similar to those of HAdV-C5 and HAdV-D26 although with some differences. The sequence and arrangement of the hexon hypervariable region 1 (HVR1) and the arrangement of the C-terminal region of protein IX differ. Variations in the penton base and hexon HVR1 may play a role in facilitating infection of intestinal cells by HAdV-F41. A unique feature of HAdV-F40 and F41, among human adenoviruses, is the presence and expression of two fibre genes, giving long and short fibre proteins. This may also contribute to the tropism of these viruses. HAdV-F41 has been linked to a recent outbreak of severe acute hepatitis "of unknown origin" in young children. Further investigation has shown a very high prevalence of adeno-associated virus-2 in the liver and/or plasma of some cohorts of patients. These observations have proved controversial as HAdV-F41 had not been reported to infect the liver and AAV-2 has generally been considered harmless.
... In this pathway, adenovirus could not infect hepatocytes. The new pathway, preliminarily, has been called "coagulationfactor dependent" and indicates the role of FIX and complement factor C4BP in the tropism of Adenovirus toward hepatocytes (5,6). Then, other studies suggest the role of other coagulation factors such as FX and FVII on AdV tropism (7,8). ...
Preprint
Full-text available
Introduction: Adenovectors are promising vectors for gene delivery to the target cells. During gene therapy, AdV interact with plasma components particularly vitamin K-dependent coagulation factors. In this study, we analyzed the comparison between cell entrance, inflammatory patterns, and innate immune induction which induced by the Adenoventor and Adenovector coated by FVII, FVIII, and FIX on two cell-lines; HepG2, MCF7. Methods: The Adenovector expressing GFP (AdVGFP) was prepared and then loading of AdV by coagulation factors were analyzed by zeta potential measurement. The non-toxic MOI of vector employed alone or in complex with coagulation factors VII, FVIII, and FIX applied on HepG2 and MCF7 cell lines. The transduction rates of complexes were analyzed by fluorescent microscopy and flow cytometry. The expression levels of innate immune genes (PKR, STING, IRF-3 and MX-1) were measured by Real-time PCR. Also the level of IL-6 and IL-1β were evaluated by using ELISA assay. Results: The loading of Adenovector by FVII and FIX decreased the zeta charge of the complex particles and enhanced the entry rate in both HepG2 (FVII/AdV: 38.3% and FIX/AdV: 61.9%) and MCF7 (FVII/AdV: 31.2% and FIX/AdV: 36.6%). The expression of IL-6 cytokine enhanced when AdV exposed to FVII (P value: 0.005) in MCF7 and also FVII (P value: 0.01) and FIX (P value: 0.009) in HepG2. Adenovector coated by FVII and FIX could significantly alter the expression pattern of innate immune genes. Conclusion: The findings are highlighted the role of FVII and in particular FIX in facilitating the entry of vector into the cells; also they are enhanced the inflammation and innate immune responses. Interestingly, FVIII had no effect or even adverse effect on entry, inflammation, and innate immune induction.
... Historically, most of the AdV are based on Ad5, but it has become evident that the natural diversity of all Ad types needs to be explored. To expand the tropism of Ads, engineered chimeric AdVs based on the commonly applied Ad5 containing modified fiber proteins derived from other Ad types (for example, Ad11, -35, -3, -40 and -37) have been introduced [19][20][21][22]. In most cases, the chimeric AdVs demonstrated higher transduction efficiency and more potent tumor cell killing. ...
Article
Full-text available
The adenovirus vector platform remains one of the most efficient toolboxes for generation of transfer vehicles used in gene therapy and virotherapy to treat tumors, as well as vaccines to protect from infectious diseases. The adenovirus genome and capsids can be modified using highly efficient techniques, and vectors can be produced at high titers, which facilitates their rapid adaptation to current needs and disease applications. Over recent years, the adenovirus vector platform has been in the center of attention for vaccine development against the ongoing coronavirus SARS-CoV-2/COVID-19 pandemic. The worldwide deployment of these vaccines has greatly deepened the knowledge on virus-host interactions and highlighted the need to further improve the effectiveness and safety not only of adenovirus-based vaccines but also of gene therapy and oncolytic virotherapy vectors. Based on the current evidence, we discuss here how adenoviral vectors can be further improved by intelligent molecular design. This review covers the full spectrum of state-of-the-art strategies to avoid vector-induced side effects ranging from the vectorization of non-canonical adenovirus types to novel genome engineering techniques.
... Adenovirus entry into host cells necessitates the presence of both primary and secondary receptors. The knob domain of fibre proteins, for starters, interacts with the coxsackievirus adenovirus receptor (CAR), which is responsible for docking Adenovirus to cells [31]. Even though species C Ads primarily interact with CAR, group B Ads primarily interact with CD46. ...
Article
Full-text available
Oncolytic viruses replicate and spread in tumors at the same time, resulting in increased cytotoxicity and the reversal of tumor immune suppression. Among other viruses, recombinant adenoviruses that replicated in tumor cells were clinically tested via intratumoral or systemic administration. Although oncolytic virus replication kills tumor cells on its own, it may also activate the immune system, which can aid in tumor control. Viruses can be modified to improve their selectivity and effectiveness. Adenovirus genomes can be easily designed to incorporate various tumor-targeting pathways and therapeutic transgenes to improve antitumor properties. Poor tumor targeting, intratumoral expansion, and virocentric immune responses are all linked to low efficacy. As a result, more effective oncolytic adenoviruses that can be used alone or in combination with chemotherapy or immunotherapy are needed. Oncolytic Adenovirus (OAds) has long been considered a potential biotherapeutic agent against various cancers due to its ability to replicate cancer cells while remaining dormant in healthy cells selectively. Several preclinical studies using genetic engineering technology have increased antitumor OAds in various cancers in recent years. Systemic OAds administration is hampered by poor targeting tropism to healthy tissues, low-level ad receptors on tumor cells, and pre-existing neutralizing antibodies. Various discoveries have been made to overcome these barriers, including stem cells, nanoparticles, polymer shielding, extracellular vesicles, hydrogels, and microparticles (MPs). These carriers may improve Oncolytic viruses’ therapeutic efficacy by improving transfection, circulatory survival, cellular interactions, specific targeting, and immune response. The structure and biology of adenoviruses, the different types of OAds, and the efficacy of different carriers in the systemic administration of OAds were all examined in this review.
... CAR, a member of the junctional adhesion molecule family, widely presents on the surface of epithelial cells, which largely determines viral tissue tropism. Nakamura et al. [43] demonstrated that the hepatocyte transduction efficiency of recombinant Ad5, containing the short fiber of Ad40, which is unable to bind to CAR, was significantly lower than that of wild type Ad5 in vitro, indicating that ablation of the fiberÀCAR interaction reduced viral transduction properties. Further, compared with Ad5, the gene transfer efficiency of dl-K420A-Z, a CAR-binding ablated Ad5 containing mutations in the fiber knob domain, is markedly decreased in different cell lines, including U343, A549, Hela, U251N, H460 and SK-Hep1. ...
Article
Adenoviruses (Ads), common self-limiting pathogens in humans and animals, usually cause conjunctivitis, mild upper respiratory tract infection or gastroenteritis in humans and hepatotoxicity syndrome in chickens and dogs, posing great threats to public health and livestock husbandry. Artificially modified Ads, which wipe out virulence-determining genes, are the most frequently used viral vectors in gene therapy, and some Ad vector (AdV)-related medicines and vaccines have been licensed and applied. Inherent liver tropism enables AdVs to specifically deliver drugs/genes to the liver; however, AdVs are closely associated with acute hepatotoxicity in immunocompromised individuals, and the side effects of AdVs, which stimulate a strong inflammatory reaction in the liver and cause acute hepatotoxicity, have largely limited clinical application. Therefore, this review systematically elucidates the intimate relationship between AdVs and hepatotoxicity in terms of virus and host and precisely illustrates the accumulated understanding in this field over the past decades. This review demonstrates the liver tropism of AdVs and molecular mechanism of AdV-induced hepatotoxicity and looks at the studies on AdV-mediated animal hepatotoxicity, which will undoubtedly deepen the understanding of AdV-caused liver injury and be of benefit in the further safe development of AdVs.
Article
Skin, the largest human organ, is part of the first line of physical and immunological defense against many pathogens. Understanding how skin antigen‐presenting cells (APCs) respond to viruses or virus‐based vaccines is crucial to develop antiviral pharmaceutics, and efficient and safe vaccines. Here, we discuss the way resident and recruited skin APCs engage adenoviruses and the impact on innate immune responses. The skin is part of the first line of physical and immunological defense against many pathogens. Understanding how antigen‐presenting cells present in the skin respond to viruses or virus‐based vaccines is critical to the development of effective and safe antiviral pharmaceuticals and vaccines. Here we discuss how resident and recruited skin antigen‐presenting cells engage directly, or indirectly, human adenoviruses, and the impact on innate immune responses.
Article
Human adenovirus serotype 41 (HAdV-F41) is an important pathogen that causes diarrhea in children. However, the data on its molecular genetic characteristics and evolutionary history are still neither comprehensive nor sufficient. Four capsid protein genes from 58 HAdV-F41-positive specimens taken from diarrheal children in Beijing during 2010–2019 were amplified and analyzed. Variant amino acids in the hexon gene (18 sites) and short fiber gene (4 sites) clustered these strains into two clades and four subclades. The deletion of 15 amino acids found in the gene seemed to have little effect on the genomic strain cluster same as to penton gene. The HAdV-F41 strains had high diversity, as assessed from the intraspecific recombination of hexon, short fiber and long fiber. The molecular evolutionary rate of HAdV-F41's concatenated genes was 4.07 × 10⁻⁵ substitutions/site/year, and it diverged from the most recent common ancestor in 1720. Apart from in the penton gene, positive selection codons were predicted in the other three genes, which may play a synergistic role in the evolution of HAdV-F41. These results provide new insights for understanding the characteristics of infectivity and developing vectors and vaccine vehicles for HAdV-F41.
Article
Full-text available
The promise of gene therapy for health care will not be realized until gene delivery systems are capable of achieving efficient, cell-specific gene delivery in vivo. Here we describe an adenoviral system for achieving cell-specific transgene expression in pulmonary endothelium. The combination of transductional targeting to a pulmonary endothelial marker (angiotensin-converting enzyme, ACE) and an endothelial-specific promoter (for vascular endothelial growth factor receptor type 1, flt-1) resulted in a synergistic, 300,000-fold improvement in the selectivity of transgene expression for lung versus the usual site of vector sequestration, the liver. This combined approach should be useful for the design of other gene delivery systems.
Article
Full-text available
We have developed a new expression vector which allows efficient selection for transfectants that express foreign genes at high levels. The vector is composed of a ubiquitously strong promoter based on the β-actin promoter, a 69% Subregion of the bovine papilloma virus genome, and a mutant neomycin phosphotransferase II-encoding gene driven by a weak promoter, which confers only marginal resistance to G418. Thus, high concentrations of G418 (approx. 800 μg/ml) effectively select for transfectants containing a high vector copy number (> 300). We tested this system by producing human interleukin-2 (IL-2) in L cells and Chinese hamster ovary (CHO) cells, and the results showed that high concentrations of G418 efficiently yielded L cell and CHO cell transfectants stably producing IL-2 at levels comparable with those previously attained using gene amplification. The vector sequences were found to have integrated into the host chromosome, and were stably maintained in the transfectants for several months.
Article
Full-text available
The gene encoding the major capsid protein (hexon) of human adenovirus type 40 (Ad40) has been isolated and sequenced. Comparison of the predicted amino acid sequence of the Ad40 hexon with the corresponding polypeptide of the human enteric adenovirus, Ad41, reveals an overall identity of 88%. The majority of the changes in sequence are located in two areas, amino acids 131 to 287 and 390 to 425. Regions in the hexon protein that vary between Ad40 and Ad41 (subgroup F) were the same regions that varied between Ad2 and Ad5 (subgroup C) suggesting that these areas of the protein represent type-specific antigenic determinants. Other areas were conserved within members of a subgroup but varied between subgroups. Fitting of the Ad40 hexon sequence to the known three-dimensional structure of the Ad2 hexon demonstrates that the variable regions are located in the 1(1), 1(2) and 1(4) loops that form the surface of the virion. Of major significance is the absence in Ad40 of the highly acidic region present in both Ad2 and Ad5. In Ad2 this region stretches down into the D-strand of the beta-barrel forming the P1 domain. Molecular modelling indicates that the amino acids in Ad40 which correspond to the acidic region of Ad2 can also be accommodated in the eight-stranded beta-barrel, thereby maintaining the integrity of the barrel. Since the acidic region is also absent from the hexon of Ad41, the sequence of amino acids that replaces the acidic residues may be responsible for some of the distinctive biological properties of the subgroup F adenoviruses.
Article
Development of adenovirus vectors as potential therapeutic agents for multiple applications of in vivo human gene therapy has resulted in numerous preclinical and clinical studies, However, lack of standardization of the methods for quantifying the physical concentration and functionally active fraction of virions in these studies has often made comparison between various studies difficult or impossible, This study was therefore carried out to define the variables for quantification of the concentration of adenovirus vectors. The methods for evaluation of total virion concentration included electron microscopy and optical absorbance, The methods for evaluation of the concentration of Functional virions included detection of gene transfer (transgene transfer and expression) and the plaque assay on 293 cells, Enumeration of total virion concentration by optical absorbance was found to be a precise procedure, but accuracy was dependent on physical disruption of the virion to eliminate artifacts from light scattering and also on a correct value for the extinction coefficient. Both biological assays for enumerating functional virions were highly dependent on the assay conditions and in particular the time of virion adsorption and adsorption, volume. Under optimal conditions, the bioactivity of the vector, defined as the fraction of total virions which leads to detected target cell infection, was determined to be 0.10 in the plaque assay and 0.29 in the gene transfer assay. This difference is most likely due to the fact that detection by gene transfer requires only measurement of levels of transgene expression in the infected cell whereas plaque formation is dependent on a series of biological events of much greater complexity. These results show that the exact conditions for determination of infectious virion concentration and bioactivity of recombinant adenovirus vectors are critical and must be standardized for comparability, These observations may be very useful in comparison of data from different preclinical and clinical studies and may also have important implications for how adenovirus vectors can optimally be used in human gene therapy.
Article
The human adenovirus serotype 5 (Ad5) is used widely for applications in human gene therapy. Cellular attachment of Ad5 is mediated by binding of the carboxyl-terminal knob of its fiber coat protein to the Coxsackie adenovirus receptor (CAR) protein. However, Ad5 binding to CAR hampers the development of adenovirus vectors capable of specifically targeting (diseased) tissues or organs. Through sequence analysis and mutagenesis, a conserved receptor-binding region was identified on the side of three divergent CAR-binding knobs. The feasibility of simultaneous CAR ablation and redirection of an adenovirus to a new receptor is demonstrated.
Article
Crystals of the fiber protein of adenovirus type 2 have been grown. Analysis of these crystals (type I crystals) showed that they were composed of fiber polypeptide with a lower apparent molecular weight (60 kDa) than that of the soluble or virion-incorporated fiber (62 kDa). N-terminal sequencing revealed that the fiber polypeptide chain of 60 kDa was cleaved at tyrosine17 from the N-end. The C-terminus remained intact. Assays with protease inhibitors suggested that the spontaneous cleavage of the fiber occurring upon its crystallization was due to a cellular, calcium-dependent, chymotrypsin-like protease co-purifying with the fiber and activated during hydroxyapatite chromatography. Crystallization of fiber purified in the presence of chymostatin provided crystals of a different structure under the electron microscope (crystals of type II), composed of 62-kDa fiber polypeptide units. The 62-kDa fiber from the type II crystals, as well as the 62-kDa fiber isolated from infected cell extracts, were able to associate with the penton base in vitro to form a penton capsomer. The 60-kDa fiber has lost this capacity. The accessibility of the N- and C-termini of the fiber inside the penton structure was probed by anti-peptide sera after limited proteolysis. The results are consistent with a polarity of the fiber in which its N-terminus is oriented toward the penton base, the C-terminal domain corresponding to the distal knob.
Article
The three antigens associated with adenovirus type 5 have been purified and investigated by electron microscopy and immunology. Antigen A is a round object 80 Å in diameter. Antigen B has a round head 80 Å in diameter attached to a tail 200 Å long and 20 Å wide with a 40 Å knob on the end. Antigen C is like antigen B without its head. Trypsin digests the head of antigen B and converts antigen B to antigen C.Antigen A forms the 240 capsomers† on the adenovirus surface that have 6 nearest neighbours. The other 12 capsomers on the vertices are antigen B and have 5 nearest neighbours. The tail on each antigen B extends outwards from the virus surface. Antigen C exists in the virion only as part of antigen B.
Article
A recombinant adenovirus (Ad) expressing Cre recombinase derived from bacteriophage P1 was constructed. To assay the Cre activity in mammalian colls, another recombinant Ad bearing an on/off-switching reporter unit, where a LacZ-expression unit can be activated by the Cre-mediated exclsionai deletion of an interposed stuffer DNA, was also constructed. Co-infection experiments together with the Cre-expressing and the reporter recombinant Ads showed that the Cre-mediated switching of gene expression was detected in nearly 100% of cultured CV1, HeLa and Jurkat cells. These results suggest that the recombinant Ad efficiently expressed functional Cre and offers a basis for estabilshing a powerful on/off switching strategy of gene expression incultured mammalian cells and presumably in transgenic animals. The method is also applicable to construction of recombinant Ad bearing a gene the expression of which is deleterious to propagation of recombinant Ad.
Article
The 49 serotypes of human adenoviruses can be divided into six subgenera (A-F; Wadell 1990; Schnurr and Dondero 1993). Members of subgenera A and F are related, displaying a tropism for the intestinal tract. Furthermore, they are difficult to cultivate in established cell lines. However, the degree of fastidiousness and the association within gastroenteritis is more pronounced for the two members Ad40 and Ad41 of subgenus F (Brown et al. 1992; Tiemessen and Kidd 1994; Uhnoo et al. 1984).
Article
The adenovirus fiber protein was first described as the “cell detaching factor” by Rowe et al. (1958), as the “early cytopathic factor” by Pereira (1958), and as the “toxin-like factor” by Everett and Ginsberg (1958). In 1965 Valentine and Pereira observed antenna-like projections extending from the vertices of HAd2 virions, and the next year Norrby (1966) observed similar, but shorter projections on HAd3 virions. These projections were called fibers by Ginsberg and coworkers (1966), and it was shown by several laboratories that they can be purified by ion exchange chromatography and visualized on denaturing polyacrylamide gels as a distinct polypeptide, characteristic of a given adenovirus serotype.